GRP
HZNP

Global Retirement Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Global Retirement Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-161
Closed -$18.7K – 3523
2023
Q3 		$18.7K Sell
161
-80
-33% -$8.6K ﹤0.01% 1672
2023
Q2 		$24.8K Buy
241
+147
+156% +$15.5K ﹤0.01% 1579
2023
Q1 		$10.4K Sell
94
-264
-74% -$29.2K ﹤0.01% 1912
2022
Q4 		$40.7K Buy
358
+6
+2% +$498 ﹤0.01% 1178
2022
Q3 		$22K Sell
352
-121
-26% -$8.46K ﹤0.01% 1359
2022
Q2 		$38K Hold
473
– – ﹤0.01% 1103
2022
Q1 		$42K Buy
+473
New +$46.1K ﹤0.01% 1070
2021
Q4 		– Sell
-253
Closed -$28K – 2027
2021
Q3 		$28K Buy
253
+74
+41% +$7.68K ﹤0.01% 1094
2021
Q2 		$17K Buy
179
+61
+52% +$5.61K ﹤0.01% 1243
2021
Q1 		$11K Buy
118
+91
+337% +$7.68K ﹤0.01% 1278
2020
Q4 		$2K Hold
27
– – ﹤0.01% 1653
2020
Q3 		$2K Buy
27
+14
+108% +$963 ﹤0.01% 1534
2020
Q2 		$1K Buy
+13
New +$556 ﹤0.01% 1588

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Global Retirement Partners's HZNP Position: Q4 2023 in Review

Global Retirement Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 161 shares — an estimated $18.7K sold.

Global Retirement Partners first reported a position in HZNP in Q2 2020 and held it in 13 quarters. The position peaked at $42K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Global Retirement Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Global Retirement Partners sold 161 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $18.7K.
  • Global Retirement Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 13 quarters.
  • Global Retirement Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $42K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Global Retirement Partners's 13F filing for Q4 2023, filed 18 Jan 2024.